Smoking cessation pharmacotherapy based on genetically-informed biomarkers: what is the evidence?
<p><strong>Introduction:</strong> Pharmacogenomic studies have used genetic variants to identify smokers likely to respond to pharmacological treatments for smoking cessation. Methods:We performed a systematic review and meta-analysis of primary and secondary analyses of trials of...
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Journal article |
| Hizkuntza: | English |
| Argitaratua: |
Oxford University Press
2019
|